Anakinra for rheumatoid arthritis: A modest benefit with some risk

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news151737380.html">Anakinra for rheumatoid arthritis: A modest benefit with some risk</a></p> <p>New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications.</p>